Susquehanna International Group’s Enzo Biochem, Inc. ENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-52,600
Closed -$117K 13933
2022
Q3
$117K Buy
52,600
+21,700
+70% +$52.4K ﹤0.01% 11550
2022
Q2
$64K Buy
30,900
+800
+3% +$1.98K ﹤0.01% 11827
2022
Q1
$87K Buy
30,100
+2,300
+8% +$7.38K ﹤0.01% 12005
2021
Q4
$89K Sell
27,800
-73,000
-72% -$249K ﹤0.01% 12217
2021
Q3
$357K Buy
100,800
+66,300
+192% +$221K ﹤0.01% 10203
2021
Q2
$109K Sell
34,500
-119,400
-78% -$376K ﹤0.01% 12053
2021
Q1
$529K Buy
153,900
+66,200
+75% +$206K ﹤0.01% 9342
2020
Q4
$221K Buy
+87,700
New +$191K ﹤0.01% 9880
2020
Q3
Sell
-11,600
Closed -$26K 11269
2020
Q2
$26K Buy
+11,600
New +$29.8K ﹤0.01% 9890
2018
Q2
Sell
-14,200
Closed -$78K 10575
2018
Q1
$78K Buy
14,200
+100
+0.7% +$704 ﹤0.01% 8805
2017
Q4
$115K Sell
14,100
-13,300
-49% -$127K ﹤0.01% 8631
2017
Q3
$287K Buy
+27,400
New +$304K ﹤0.01% 7483
2016
Q1
Sell
-31,600
Closed -$142K 9792
2015
Q4
$142K Sell
31,600
-2,100
-6% -$8.87K ﹤0.01% 8688
2015
Q3
$107K Buy
+33,700
New +$102K ﹤0.01% 9106
2014
Q3
Sell
-29,000
Closed -$152K 10033
2014
Q2
$152K Sell
29,000
-18,100
-38% -$78.3K ﹤0.01% 9239
2014
Q1
$196K Buy
47,100
+13,600
+41% +$46.6K ﹤0.01% 8255
2013
Q4
$98K Buy
33,500
+20,100
+150% +$49.9K ﹤0.01% 8646
2013
Q3
$34K Sell
13,400
-4,600
-26% -$10.9K ﹤0.01% 8283
2013
Q2
$37K Buy
+18,000
New +$39.7K ﹤0.01% 8029

Other funds holding ENZ

Susquehanna International Group's ENZ Position: Q2 2025 in Review

Susquehanna International Group sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 60,041 shares — an estimated $22.2K sold.

Susquehanna International Group first reported a position in ENZ in Q2 2013 and held it in 32 quarters. The position peaked at $734K in Q2 2017. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Susquehanna International Group reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 60,041 Enzo Biochem, Inc. shares in Q2 2025, an estimated $22.2K.
  • Susquehanna International Group first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 32 quarters.
  • Susquehanna International Group's Enzo Biochem, Inc. position peaked at $734K in Q2 2017.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.